Ignite Creation Date:
2025-12-24 @ 7:54 PM
Ignite Modification Date:
2026-03-27 @ 8:32 AM
Study NCT ID:
NCT03801304
Status:
COMPLETED
Last Update Posted:
2022-05-12
First Post:
2019-01-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer
Sponsor:
University Hospital, Brest
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
29BRC18-0005 (VinMetAtezo)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None